Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Tacalcitol cream effectively and safely treated a rare skin condition called Lichen Spinulosus in two cases.

Baricitinib may effectively treat lichen planopilaris.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.

An 18-year-old girl improved with treatment after being diagnosed with both Systemic Lupus Erythematosus and Celiac Disease.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

The effectiveness of statins for women with PCOS is unclear.

Ocrelizumab may cause total body hair loss in some patients.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

The FDA approved a new Pfizer drug for hair loss in teens.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Cetirizine is effective and safe for treating various allergies, with personalized dosing improving its use.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

High-dose iron therapy improves anemia without affecting IBD treatment.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

HPLC may detect prediabetes and diabetes earlier than Immunoturbidimetry because it shows higher A1c levels.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Upadacitinib may effectively treat resistant lichen planopilaris.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Ruxolitinib can cause a delayed skin reaction on the nose.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.